Atara Biotherapeutics Inc (ATRA): Total Asset Value of Company
Atara Biotherapeutics (ATRA) develops innovative cell therapies to combat oncology and sclerosis. The stock's price history reflects the dynamics of total assets, which amount to 28.97. The uniqueness of its technologies and European regulatory approval for its drug secure the company's status as a market leader. Meanwhile, the stability of the R&D center is maintained through the targeted hiring of regulatory experts and the retention of leading scientists.
Comprehensive metric breakdowns and analytics for atarabio.com (ATRA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:ATRA, Atara Biotherapeutics Inc
The scale of Atara Biotherapeutics operations in developing complex allogeneic drugs determines the company's current financial asset value at 28.97. This metric, reverse-calculated via ROA, consolidates the value of all resources and liabilities, allowing investors to assess the capitalization efficiency of the Ebvallo technological advantage and the resilience of the business's material base amid high barriers to entry in the cell therapy niche.
Competitors of Atara Biotherapeutics (ATRA)
ARGX (argenx.com) - Company Total Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Savara Corp - Company Total Assets|Rigel Corp (RIGL) - Company Total Assets|ANAB - Cumulative Company Assets|astriatx.com (ATXS) - Aggregate Business Assets|ENGN (enGene) - Company Total Assets|Company Total Assets RAPT|Aerovate Therapeutics Inc (JBIO) - Aggregate Company Assets|Aggregate Asset Value Aclaris Therapeutics, Inc (ACRS)|Company Total Assets KYTX (Kyverna Therapeutics)|TLSA - Company Total Assets|Cumulative Company Assets Cabaletta Bio (CABA)|VTYX - Aggregate Asset Value|Theratechnologies Inc (THTX) - Company Total Assets|Avalo Therapeutics Inc (AVTX) - Aggregate Company Assets|ELDN: Company Total Assets|Company Total Asset Base AGEN|Climb Bio - Aggregate Company Assets|Company Assets Zura Bio Ltd ZURA|Cumulative Company Assets aTyr (ATYR)|Aggregate Business Assets Adagene Inc ADAG|Company Total Assets Ikena Oncology, Inc. (IMA)|STTK - Aggregate Asset Value|Company Total Assets EQ|CNTB (Connect Biopharma Holdings Limited) - Company Assets|IMUX - Aggregate Company Assets|Aggregate Asset Value InflaRx GmbH|Company Total Assets XFOR|Company Total Assets ACET (adicetbio.com)|Celularity (CELU) - Aggregate Company Assets|Total Asset Value of Company INmune Bio Inc INMB|BRNS (Barinthus Bio) - Company Total Assets|Kezar Life Sciences Inc (KZR) - Company Assets|SABS: Cumulative Company Assets|Company Total Assets akaritx.com|Enlivex Therapeutics Ltd (ENLV) - Cumulative Company Assets|Aggregate Business Assets Q32 Bio Corp|GOVX (GeoVax Labs Inc) - Company Total Assets|Company Total Asset Base Edesa Biotech Corp (EDSA)|iBio, Inc. - Company Total Assets|Carisma Therapeutics Inc - Cumulative Company Assets|Aggregate Company Assets XTLB (XTL Biopharmaceuticals Ltd.)|BOLT - Company Total Asset Base|HCWB: Company Total Assets|Company Total Assets Aptevo Therapeutics Inc.|AIM ImmunoTech Inc. (AIM) - Cumulative Company Assets|Aggregate Business Assets ADTX|GRI Bio (GRI) - Aggregate Company Assets|Aggregate Asset Value XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|Revelation Biosciences Corp - Company Total Assets|Aggregate Company Assets Indaptus Therapeutics|SCNI - Total Asset Value of Company|Company Total Assets calcimedica.com CALI|Affimed N.V. (AFMD) - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOK|IGM Biosciences, Inc. (IGMS) - Aggregate Company Assets|Aggregate Asset Value ITOS (iteostherapeutics.com)|Ocean Biomedical - Aggregate Company Assets|Cumulative Company Assets TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc - Company Total Assets